Research recently completed by the National Institute of Health Research (NIHR) has determined that the commonly used acne medication minocycline may also be used for the treatment of schizophrenia.
After the initial study, NIHR will put an additional $1.9 million into further researching this theory. The acne medication was originally discovered as a potential treatment for schizophrenia after the drug was prescribed to patients in Japan. These patients saw significant improvements in the symptoms of their illness after taking the medication.
Further studies still need to be done to see if minocycline is another potential treatment for this schizophrenia. If studies are successful, it will be a significant achievement for mental health research. The medication is also cost effective.
Testing will be done in different countries, such as Pakistan, Brazil, and Israel, to assess if the acne medication can, in fact, be used as a schizophrenia treatment option.
Source—Top NewsView Article